Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.220
-0.055 (-2.42%)
At close: Dec 5, 2025, 4:00 PM EST
2.240
+0.020 (0.90%)
After-hours: Dec 5, 2025, 7:30 PM EST
Neumora Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -236.3 | -243.79 | -235.93 | -130.9 | -237.31 | -99.27 | |
| Depreciation & Amortization | 0.36 | 0.63 | 0.67 | 0.59 | 0.54 | 0.11 | |
| Asset Writedown & Restructuring Costs | - | - | 63.9 | 13 | 157 | 69.86 | |
| Loss (Gain) From Sale of Investments | -3.88 | -5.72 | -3.74 | -0.71 | - | - | |
| Stock-Based Compensation | 32.37 | 39.99 | 17.24 | 8.3 | 4.27 | 1.68 | |
| Other Operating Activities | 3.25 | 3.31 | 3.48 | 1.77 | 1.04 | 3.99 | |
| Change in Accounts Payable | -5.66 | 2.87 | -0.58 | -1.25 | -0.76 | -4.67 | |
| Change in Other Net Operating Assets | 0.65 | 19.76 | -8.32 | -5.7 | -0.2 | 1.55 | |
| Operating Cash Flow | -208.83 | -182.94 | -163.28 | -114.9 | -75.42 | -26.76 | |
| Capital Expenditures | 0.76 | - | -0.12 | -0.51 | -0.82 | -1.3 | |
| Cash Acquisitions | - | - | - | - | - | 2.81 | |
| Sale (Purchase) of Intangibles | -0.78 | -0.78 | -4.59 | -13 | - | - | |
| Investment in Securities | 26.92 | -69.78 | 69.09 | -154.5 | - | - | |
| Other Investing Activities | - | - | - | - | - | -12.75 | |
| Investing Cash Flow | 27.08 | -70.56 | 64.39 | -168.01 | -0.82 | -11.24 | |
| Long-Term Debt Issued | - | - | - | - | - | 55.91 | |
| Net Debt Issued (Repaid) | 18.26 | - | - | - | - | 55.91 | |
| Issuance of Common Stock | 15.41 | 21.6 | 236.23 | 2.66 | 3.47 | 3.19 | |
| Repurchase of Common Stock | - | - | -0.49 | - | - | -0 | |
| Other Financing Activities | 0.23 | - | -3.8 | -0.92 | -1.21 | -0.9 | |
| Financing Cash Flow | 33.89 | 21.6 | 231.94 | 115.74 | 293.51 | 230.1 | |
| Net Cash Flow | -147.86 | -231.89 | 133.05 | -167.17 | 217.27 | 192.1 | |
| Free Cash Flow | -208.07 | -182.94 | -163.4 | -115.41 | -76.24 | -28.06 | |
| Free Cash Flow Per Share | -1.29 | -1.15 | -2.51 | -4.24 | -3.48 | -2.16 | |
| Cash Income Tax Paid | - | 0.47 | - | - | - | - | |
| Levered Free Cash Flow | -120.07 | -100.7 | -111.24 | -93.02 | -37.08 | - | |
| Unlevered Free Cash Flow | -119.33 | -100.7 | -111.24 | -93.02 | -37.08 | - | |
| Change in Working Capital | -5 | 22.64 | -8.9 | -6.95 | -0.96 | -3.12 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.